|
MechanismIL-1β inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.IT |
First Approval Date01 Dec 1986 |
100 Clinical Results associated with Proter Srl
0 Patents (Medical) associated with Proter Srl
100 Deals associated with Proter Srl
100 Translational Medicine associated with Proter Srl